JP2005500325A5 - - Google Patents

Download PDF

Info

Publication number
JP2005500325A5
JP2005500325A5 JP2003511875A JP2003511875A JP2005500325A5 JP 2005500325 A5 JP2005500325 A5 JP 2005500325A5 JP 2003511875 A JP2003511875 A JP 2003511875A JP 2003511875 A JP2003511875 A JP 2003511875A JP 2005500325 A5 JP2005500325 A5 JP 2005500325A5
Authority
JP
Japan
Prior art keywords
group
independently
formula
compound
chelating agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003511875A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005500325A (ja
JP5015409B2 (ja
Filing date
Publication date
Priority claimed from GBGB0116815.2A external-priority patent/GB0116815D0/en
Application filed filed Critical
Publication of JP2005500325A publication Critical patent/JP2005500325A/ja
Publication of JP2005500325A5 publication Critical patent/JP2005500325A5/ja
Application granted granted Critical
Publication of JP5015409B2 publication Critical patent/JP5015409B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003511875A 2001-07-10 2002-07-10 改良キレート剤結合体 Expired - Lifetime JP5015409B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0116815.2A GB0116815D0 (en) 2001-07-10 2001-07-10 Improved chelator conjugates
GB0116815.2 2001-07-10
PCT/GB2002/003168 WO2003006070A2 (en) 2001-07-10 2002-07-10 Improved chelator conjugates

Publications (3)

Publication Number Publication Date
JP2005500325A JP2005500325A (ja) 2005-01-06
JP2005500325A5 true JP2005500325A5 (https=) 2006-01-05
JP5015409B2 JP5015409B2 (ja) 2012-08-29

Family

ID=9918227

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003511875A Expired - Lifetime JP5015409B2 (ja) 2001-07-10 2002-07-10 改良キレート剤結合体

Country Status (20)

Country Link
US (2) US7597875B2 (https=)
EP (1) EP1404377B1 (https=)
JP (1) JP5015409B2 (https=)
KR (1) KR100892009B1 (https=)
CN (4) CN101538313A (https=)
AT (1) ATE304866T1 (https=)
AU (1) AU2002317317B2 (https=)
BR (1) BR0210965A (https=)
CA (1) CA2450690C (https=)
DE (1) DE60206272T2 (https=)
DK (1) DK1404377T3 (https=)
ES (1) ES2250671T3 (https=)
GB (1) GB0116815D0 (https=)
HU (1) HU228850B1 (https=)
IL (1) IL159388A0 (https=)
MX (1) MXPA04000210A (https=)
NO (1) NO334093B1 (https=)
RU (1) RU2298012C2 (https=)
WO (1) WO2003006070A2 (https=)
ZA (1) ZA200400143B (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6972122B2 (en) * 2001-01-05 2005-12-06 Duke University Contrast enhancement agent for magnetic resonance imaging
WO2003006491A2 (en) * 2001-07-10 2003-01-23 Amersham Health As Peptide-based compounds for targeting intergin receptors
NO20030115D0 (no) 2003-01-09 2003-01-09 Amersham Health As Kontrastmiddel
EP1699495A2 (en) 2003-11-06 2006-09-13 Amersham Health AS Conjugates of angiotensin ii and an imaging moiety
GB0416062D0 (en) * 2004-07-19 2004-08-18 Amersham Plc Improved N4 chelator conjugates
JP2007512321A (ja) * 2003-11-24 2007-05-17 ジーイー・ヘルスケア・アクスイェ・セルスカプ 造影剤
JP2007526300A (ja) * 2004-03-04 2007-09-13 ジーイー・ヘルスケア・アクスイェ・セルスカプ 医薬化合物
ES2358745T3 (es) 2004-11-22 2011-05-13 Ge Healthcare As Agentes de contraste para señalar matriz extracelular.
GB0427392D0 (en) * 2004-12-15 2005-01-19 Amersham Plc Stabilised 99mTc compositions
WO2006131803A2 (en) * 2005-06-08 2006-12-14 Ge Healthcare Limited Method for the use of [11c] carbon monoxide in labeling synthesis of 11c-labelled esters and acids by sensitized photo-induced free radical carbonylation
GB0515974D0 (en) * 2005-08-03 2005-09-07 Ge Healthcare Ltd Compounds and imaging methods
WO2007094683A1 (en) 2006-02-15 2007-08-23 Ge Healthcare As Contrast agents
US7943117B2 (en) * 2006-06-08 2011-05-17 Atomic Energy Council—Institute of Nuclear Research Method for testing radiochemical purity of Tc-99m-TRODAT-1
KR20090097868A (ko) * 2006-12-11 2009-09-16 지이 헬스케어 에이에스 방사선 표지된 펩티드 기재 화합물 및 그의 용도
US9701694B2 (en) 2008-12-02 2017-07-11 The University Of Melbourne Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals
GB0922014D0 (en) 2009-12-17 2010-02-03 Ge Healthcare Ltd Novel integrin binders
EP2598175B1 (en) * 2010-07-27 2020-05-20 Serac Healthcare Limited Radiopharmaceutical compositions
GB201103696D0 (en) 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
GB201110767D0 (en) 2011-06-24 2011-08-10 Ge Healthcare Ltd Infection imaging
US20130195756A1 (en) 2012-01-31 2013-08-01 General Electric Company 99mTc IMAGING AGENTS AND METHODS OF USE
JP2016510342A (ja) * 2013-02-15 2016-04-07 トーマス・ジェファーソン・ユニバーシティＴｈｏｍａｓ Ｊｅｆｆｅｒｓｏｎ Ｕｎｉｖｅｒｓｉｔｙ 腫瘍画像化のためのキット
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
EP3131585B1 (en) 2014-03-19 2020-07-15 Universität Zürich Multidentate bifunctional chelating agents for radionuclide complexation in diagnostics and therapy
WO2019217571A1 (en) * 2018-05-08 2019-11-14 University Of Miami Materials and methods for the delivery of therapeutic nucleic acids to tissues
EP3793619A4 (en) 2018-05-16 2022-01-12 Emory University Styrylbenzothiazole derivatives and uses in imaging
CN111548275A (zh) * 2020-05-27 2020-08-18 龙曦宁（上海）医药科技有限公司 一种2-（氨基甲基）-n1,n1-二甲基丙烷-1,3-二胺三盐酸盐的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1588978A (en) * 1977-07-19 1981-05-07 Ici Ltd Coating processes
DE3930674A1 (de) * 1989-09-11 1991-03-21 Diagnostikforschung Inst Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US5808091A (en) * 1991-10-29 1998-09-15 Bracco International B.V. Rhenium and technetium complexes containing a hypoxia localizing moiety
CA2168652A1 (en) * 1993-08-04 1995-02-16 Colin Mill Archer Radiometal complexes that localise in hypoxic tissue
WO1995019187A1 (en) * 1994-01-12 1995-07-20 Amersham International Plc Biological targeting agents
CA2156605A1 (en) * 1994-01-12 1995-07-20 Bracco International B.V. Ligands and metal complexes thereof
IL139385A (en) 1998-05-15 2005-09-25 Amersham Plc Labelled glutamine and lysine analogues, metal complexes thereof, and uses thereof for diagnosis
US6783711B2 (en) * 2000-05-23 2004-08-31 Ge Osmonics, Inc. Process for preparing a sulfonamide polymer matrix
WO2002072718A1 (en) * 2001-03-08 2002-09-19 Matsushita Electric Industrial Co., Ltd. Inkjet recording ink, method for producing said ink, and ink cartridge and recording device having said ink

Similar Documents

Publication Publication Date Title
JP2005500325A5 (https=)
RU2003137592A (ru) Улучшенные хелатные конъюгаты
JP2021073272A5 (https=)
JP2005053931A5 (https=)
PE20090611A1 (es) Procedimiento para sintetizar compuestos utiles para tratar hepatitis c
JP2010514786A5 (https=)
JP2008509166A5 (https=)
JP2004533444A5 (https=)
JP2005511697A5 (https=)
JP2003306481A5 (https=)
JP2002508375A5 (https=)
JP2010524965A5 (https=)
EP2308828A3 (en) CaSR antagonist
HRP20121026T1 (hr) Postupak za dobivanje kaspofungina i njegovih intermedijera
JP2005536503A5 (https=)
JP2001261662A5 (https=)
CA2530584A1 (en) Composition and method for diversion agents for acid stimulation of subterranean formations
EP1857459A3 (en) Pyrazolopyrimidine compound and a process for preparing the same
JP2004529172A5 (https=)
JP2012518649A5 (https=)
RU2003134629A (ru) Соединения цефема
EP2551266A8 (en) 2',2-dithiazol non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof
JP2004538278A5 (https=)
JP2005514512A5 (https=)
JP2005516898A5 (https=)